{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/53310"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/53310","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Hypertensive disorders of pregnancy: antenatal risk factors and postpartum recovery in a diverse U.S. safety-net population","abstract":"Hypertensive disorders of pregnancy (HDP) are a leading cause of maternal morbidity and mortality in the United States (U.S.)., with racial and ethnic disparities well-documented. However, the evidence base informing HDP risk stratification and postpartum management has been derived predominantly from racially homogeneous cohorts. This dissertation examined risk factors for HDP and postpartum blood pressure (BP) recovery following an HDP diagnosis across three studies leveraging clinical and digital health data from Boston Medical Center (BMC), the largest safety-net hospital in New England. In Aim 1, we estimated associations between U.S. Preventative Services Task Force (USPSTF) identified risk factors and HDP among 6,402 deliveries at BMC from 2015-2019 and compared estimates before and after a quality improvement initiative that expanded preeclampsia screening and low-dose aspirin prescribing. The magnitude of associations did not consistently align with the established USPSTF high- versus moderate-level categorization; nulliparity (adjusted risk ratio or aRR range: 1.50-1.83) and obesity (aRR range: 1.63-1.81) had associations comparable to multifetal gestation (aRR range: 1.78-1.91), despite their moderate-level designation. Following the initiative, overall HDP prevalence declined from 14.2% to 12.3%, and adjusted associations were attenuated for most risk factors. In Aim 2, we used group-based trajectory modeling among 5,417 deliveries at BMC from 2016-2024 to identify four distinct early pregnancy systolic blood pressure (SBP) trajectory groups prior to 20 weeks' gestation: Very low-stable, Low-stable, Moderate-stable, and Elevated-stable. Compared to the Very low-stable group, the risk of HDP increased monotonically across trajectory groups (aRR: 1.66, 95% CI: 1.28, 2.16 for Low-stable; aRR: 3.12, 95% CI: 2.42, 4.02 for Moderate-stable; aRR: 4.84, 95% CI: 3.73, 6.30 for Elevated-stable), a gradient that persisted within strata of maternal race and ethnicity and body mass index, with greater magnitude among non-Hispanic Black and Hispanic patients and among patients with obesity. In Aim 3, we estimated time to BP stabilization in the first six weeks postpartum among 1,773 patients with HDP enrolled in a cellular-enabled remote BP monitoring program at BMC from 2021-2023. Sustained medication-free BP stabilization wasuncommon (11.1%). Patients with gestational hypertension (adjusted hazard ratio or aHR: 1.89, 95% CI: 1.37, 2.61) and delivery hypertension (aHR: 2.39, 95% CI: 1.50, 3.80) achieved sustained stabilization at about twice the rate of patients with preeclampsia, though these differences were largely absent among patients never prescribed antihypertensive medication. Non-Hispanic Black patients were less likely to achieve BP stabilization and took longer to stabilize across all HDP subtypes. Collectively, these findings highlight the need to re-evaluate HDP risk stratification and postpartum hypertension management in diverse, lower-resourced populations, where the populations most affected by HDP remain underrepresented in the evidence base informing current clinical guidelines.","abstract_html":"Hypertensive disorders of pregnancy (HDP) are a leading cause of maternal morbidity and mortality in the United States (U.S.)., with racial and ethnic disparities well-documented. However, the evidence base informing HDP risk stratification and postpartum management has been derived predominantly from racially homogeneous cohorts. This dissertation examined risk factors for HDP and postpartum blood pressure (BP) recovery following an HDP diagnosis across three studies leveraging clinical and digital health data from Boston Medical Center (BMC), the largest safety-net hospital in New England. In Aim 1, we estimated associations between U.S. Preventative Services Task Force (USPSTF) identified risk factors and HDP among 6,402 deliveries at BMC from 2015-2019 and compared estimates before and after a quality improvement initiative that expanded preeclampsia screening and low-dose aspirin prescribing. The magnitude of associations did not consistently align with the established USPSTF high- versus moderate-level categorization; nulliparity (adjusted risk ratio or aRR range: 1.50-1.83) and obesity (aRR range: 1.63-1.81) had associations comparable to multifetal gestation (aRR range: 1.78-1.91), despite their moderate-level designation. Following the initiative, overall HDP prevalence declined from 14.2% to 12.3%, and adjusted associations were attenuated for most risk factors. In Aim 2, we used group-based trajectory modeling among 5,417 deliveries at BMC from 2016-2024 to identify four distinct early pregnancy systolic blood pressure (SBP) trajectory groups prior to 20 weeks&#x27; gestation: Very low-stable, Low-stable, Moderate-stable, and Elevated-stable. Compared to the Very low-stable group, the risk of HDP increased monotonically across trajectory groups (aRR: 1.66, 95% CI: 1.28, 2.16 for Low-stable; aRR: 3.12, 95% CI: 2.42, 4.02 for Moderate-stable; aRR: 4.84, 95% CI: 3.73, 6.30 for Elevated-stable), a gradient that persisted within strata of maternal race and ethnicity and body mass index, with greater magnitude among non-Hispanic Black and Hispanic patients and among patients with obesity. In Aim 3, we estimated time to BP stabilization in the first six weeks postpartum among 1,773 patients with HDP enrolled in a cellular-enabled remote BP monitoring program at BMC from 2021-2023. Sustained medication-free BP stabilization wasuncommon (11.1%). Patients with gestational hypertension (adjusted hazard ratio or aHR: 1.89, 95% CI: 1.37, 2.61) and delivery hypertension (aHR: 2.39, 95% CI: 1.50, 3.80) achieved sustained stabilization at about twice the rate of patients with preeclampsia, though these differences were largely absent among patients never prescribed antihypertensive medication. Non-Hispanic Black patients were less likely to achieve BP stabilization and took longer to stabilize across all HDP subtypes. Collectively, these findings highlight the need to re-evaluate HDP risk stratification and postpartum hypertension management in diverse, lower-resourced populations, where the populations most affected by HDP remain underrepresented in the evidence base informing current clinical guidelines.","abstract_has_math":false,"creators":["Mujic, Ema"],"institution":"Boston University","degree_name":"Doctor of Philosophy","degree_level":"doctoral","degree_discipline":"Epidemiology","degree_department":null,"school":null,"contributors":[],"advisors":["Parker Kelleher, Samantha E."],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-19T02:42:12Z","subjects":["Epidemiology"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[{"key":"dc:identifier.orcid","label":"ORCID","values":["0000-0001-9702-0099"],"render_values":[{"text":"0000-0001-9702-0099","href":"https://orcid.org/0000-0001-9702-0099","code":true}]}]},"links":{"outbound_url":"https://hdl.handle.net/2144/53310","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/53310","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F53310","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Parker Kelleher, Samantha E."]},{"key":"dc:creator","label":"Author","values":["Mujic, Ema"]},{"key":"dc:identifier.orcid","label":"ORCID","values":["0000-0001-9702-0099"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2026-07-14T14:31:44Z"]},{"key":"dc:date.embargo","label":"Dc Date Embargo","values":["2028-07-07T00:00:00Z"]},{"key":"dc:date.issued","label":"Date","values":["2026"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2026-07-07T22:03:39Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Epidemiology"]},{"key":"thesis:degree_level","label":"Degree Level","values":["doctoral"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Epidemiology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/53310"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["2026"]},{"key":"dc:description.abstract","label":"Abstract","values":["Hypertensive disorders of pregnancy (HDP) are a leading cause of maternal morbidity and mortality in the United States (U.S.)., with racial and ethnic disparities well-documented. However, the evidence base informing HDP risk stratification and postpartum management has been derived predominantly from racially homogeneous cohorts. This dissertation examined risk factors for HDP and postpartum blood pressure (BP) recovery following an HDP diagnosis across three studies leveraging clinical and digital health data from Boston Medical Center (BMC), the largest safety-net hospital in New England. In Aim 1, we estimated associations between U.S. Preventative Services Task Force (USPSTF) identified risk factors and HDP among 6,402 deliveries at BMC from 2015-2019 and compared estimates before and after a quality improvement initiative that expanded preeclampsia screening and low-dose aspirin prescribing. The magnitude of associations did not consistently align with the established USPSTF high- versus moderate-level categorization; nulliparity (adjusted risk ratio or aRR range: 1.50-1.83) and obesity (aRR range: 1.63-1.81) had associations comparable to multifetal gestation (aRR range: 1.78-1.91), despite their moderate-level designation. Following the initiative, overall HDP prevalence declined from 14.2% to 12.3%, and adjusted associations were attenuated for most risk factors. In Aim 2, we used group-based trajectory modeling among 5,417 deliveries at BMC from 2016-2024 to identify four distinct early pregnancy systolic blood pressure (SBP) trajectory groups prior to 20 weeks' gestation: Very low-stable, Low-stable, Moderate-stable, and Elevated-stable. Compared to the Very low-stable group, the risk of HDP increased monotonically across trajectory groups (aRR: 1.66, 95% CI: 1.28, 2.16 for Low-stable; aRR: 3.12, 95% CI: 2.42, 4.02 for Moderate-stable; aRR: 4.84, 95% CI: 3.73, 6.30 for Elevated-stable), a gradient that persisted within strata of maternal race and ethnicity and body mass index, with greater magnitude among non-Hispanic Black and Hispanic patients and among patients with obesity. In Aim 3, we estimated time to BP stabilization in the first six weeks postpartum among 1,773 patients with HDP enrolled in a cellular-enabled remote BP monitoring program at BMC from 2021-2023. Sustained medication-free BP stabilization wasuncommon (11.1%). Patients with gestational hypertension (adjusted hazard ratio or aHR: 1.89, 95% CI: 1.37, 2.61) and delivery hypertension (aHR: 2.39, 95% CI: 1.50, 3.80) achieved sustained stabilization at about twice the rate of patients with preeclampsia, though these differences were largely absent among patients never prescribed antihypertensive medication. Non-Hispanic Black patients were less likely to achieve BP stabilization and took longer to stabilize across all HDP subtypes. Collectively, these findings highlight the need to re-evaluate HDP risk stratification and postpartum hypertension management in diverse, lower-resourced populations, where the populations most affected by HDP remain underrepresented in the evidence base informing current clinical guidelines."]},{"key":"dc:title","label":"Title","values":["Hypertensive disorders of pregnancy: antenatal risk factors and postpartum recovery in a diverse U.S. safety-net population"]}]}],"canonical_facts":{"dc:contributor.advisor":["Parker Kelleher, Samantha E."],"dc:creator":["Mujic, Ema"],"dc:date.accessioned":["2026-07-14T14:31:44Z"],"dc:date.embargo":["2028-07-07T00:00:00Z"],"dc:date.issued":["2026"],"dc:date.updated":["2026-07-07T22:03:39Z"],"dc:description":["2026"],"dc:description.abstract":["Hypertensive disorders of pregnancy (HDP) are a leading cause of maternal morbidity and mortality in the United States (U.S.)., with racial and ethnic disparities well-documented. However, the evidence base informing HDP risk stratification and postpartum management has been derived predominantly from racially homogeneous cohorts. This dissertation examined risk factors for HDP and postpartum blood pressure (BP) recovery following an HDP diagnosis across three studies leveraging clinical and digital health data from Boston Medical Center (BMC), the largest safety-net hospital in New England. In Aim 1, we estimated associations between U.S. Preventative Services Task Force (USPSTF) identified risk factors and HDP among 6,402 deliveries at BMC from 2015-2019 and compared estimates before and after a quality improvement initiative that expanded preeclampsia screening and low-dose aspirin prescribing. The magnitude of associations did not consistently align with the established USPSTF high- versus moderate-level categorization; nulliparity (adjusted risk ratio or aRR range: 1.50-1.83) and obesity (aRR range: 1.63-1.81) had associations comparable to multifetal gestation (aRR range: 1.78-1.91), despite their moderate-level designation. Following the initiative, overall HDP prevalence declined from 14.2% to 12.3%, and adjusted associations were attenuated for most risk factors. In Aim 2, we used group-based trajectory modeling among 5,417 deliveries at BMC from 2016-2024 to identify four distinct early pregnancy systolic blood pressure (SBP) trajectory groups prior to 20 weeks' gestation: Very low-stable, Low-stable, Moderate-stable, and Elevated-stable. Compared to the Very low-stable group, the risk of HDP increased monotonically across trajectory groups (aRR: 1.66, 95% CI: 1.28, 2.16 for Low-stable; aRR: 3.12, 95% CI: 2.42, 4.02 for Moderate-stable; aRR: 4.84, 95% CI: 3.73, 6.30 for Elevated-stable), a gradient that persisted within strata of maternal race and ethnicity and body mass index, with greater magnitude among non-Hispanic Black and Hispanic patients and among patients with obesity. In Aim 3, we estimated time to BP stabilization in the first six weeks postpartum among 1,773 patients with HDP enrolled in a cellular-enabled remote BP monitoring program at BMC from 2021-2023. Sustained medication-free BP stabilization wasuncommon (11.1%). Patients with gestational hypertension (adjusted hazard ratio or aHR: 1.89, 95% CI: 1.37, 2.61) and delivery hypertension (aHR: 2.39, 95% CI: 1.50, 3.80) achieved sustained stabilization at about twice the rate of patients with preeclampsia, though these differences were largely absent among patients never prescribed antihypertensive medication. Non-Hispanic Black patients were less likely to achieve BP stabilization and took longer to stabilize across all HDP subtypes. Collectively, these findings highlight the need to re-evaluate HDP risk stratification and postpartum hypertension management in diverse, lower-resourced populations, where the populations most affected by HDP remain underrepresented in the evidence base informing current clinical guidelines."],"dc:identifier.orcid":["0000-0001-9702-0099"],"dc:identifier.uri":["https://hdl.handle.net/2144/53310"],"dc:language.iso":["en_US"],"dc:subject":["Epidemiology"],"dc:title":["Hypertensive disorders of pregnancy: antenatal risk factors and postpartum recovery in a diverse U.S. safety-net population"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Epidemiology"],"thesis:degree_level":["doctoral"],"thesis:degree_name":["Doctor of Philosophy"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-19T02:42:12Z"}